These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 1374445)
1. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used. Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4. Rigley KP; Callard RE Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000 [TBL] [Abstract][Full Text] [Related]
3. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. Zhang K; Clark EA; Saxon A J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40. Gordon J; Katira A; Strain AJ; Gillis S Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of B lymphocytes via CD72 (human Lyb-2). Kamal M; Katira A; Gordon J Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426 [TBL] [Abstract][Full Text] [Related]
6. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085 [TBL] [Abstract][Full Text] [Related]
7. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. Punnonen J; de Vries JE J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958 [TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory role of CD40 in human B cell differentiation. Splawski JB; Fu SM; Lipsky PE J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424 [TBL] [Abstract][Full Text] [Related]
9. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently. Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130 [TBL] [Abstract][Full Text] [Related]
10. Soluble forms of CD40 inhibit biologic responses of human B cells. Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075 [TBL] [Abstract][Full Text] [Related]
11. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. Luo HY; Hofstetter H; Banchereau J; Delespesse G J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018 [TBL] [Abstract][Full Text] [Related]
12. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. Golay J; Cusmano G; Introna M J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals. Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477 [TBL] [Abstract][Full Text] [Related]
14. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms. Smith SH; Rigley KP; Callard RE Immunology; 1991 Jul; 73(3):293-7. PubMed ID: 1715315 [TBL] [Abstract][Full Text] [Related]
15. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens. Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Kindler V; Matthes T; Jeannin P; Zubler RH Eur J Immunol; 1995 May; 25(5):1239-43. PubMed ID: 7539752 [TBL] [Abstract][Full Text] [Related]
17. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation. Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212 [TBL] [Abstract][Full Text] [Related]
18. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243 [TBL] [Abstract][Full Text] [Related]
19. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. Kansas GS; Tedder TF J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639 [TBL] [Abstract][Full Text] [Related]
20. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus. Larson AW; LeBien TW J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]